Shionogi pays $2B to acquire a rare disease startup
Published . Updated .
The acquisition of Texas-based IntraBio adds to a growing rare disease business for Shionogi by handing the company a marketed treatment for two inherited conditions.
Directly affected
- No company is named in this report.
Indirectly affected
- REMX VANECK RARE EARTH AND STRATEGIC METALS ETF
GA selected REMX as a RELATED security because its canonical security name directly matches this event's themes: rare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| REMX | — | — | — | — | — | — | — |
The acquisition of Texas-based IntraBio adds to a growing rare disease business for Shionogi by handing the company a marketed treatment for two inherited conditions.
Source: BioPharma Dive
The price since 5 Oct 2026: Vaneck Rare Earth And Strategic Metals Etf (REMX) versus the S&P 500
Since the first closing price after “Shionogi pays $2B to acquire a rare disease startup,” Vaneck Rare Earth And Strategic Metals Etf (REMX) is -16.47%. The S&P 500 fund (SPY) is -1.60% over the same days, a -14.87% difference versus the market.
Who gains and who loses around Vaneck Rare Earth And Strategic Metals Etf (REMX)
Companies tied to this story
- REMX Vaneck Rare Earth And Strategic Metals Etf
In “Shionogi pays $2B to acquire a rare disease startup,” Vaneck Rare Earth And Strategic Metals Etf (REMX) is linked, with no stored direction, medium confidence. Reason on file: GA selected REMX as a RELATED security because its canonical security name directly matches this event's themes: rare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “Shionogi pays $2B to acquire a rare disease startup” reaches Vaneck Rare Earth And Strategic Metals Etf (REMX)
Vaneck Rare Earth And Strategic Metals Etf (REMX) is the company in “Shionogi pays $2B to acquire a rare disease startup,” the 5 Oct 2026 this story story.
For Vaneck Rare Earth And Strategic Metals Etf (REMX), the reason on file says GA selected REMX as a RELATED security because its canonical security name directly matches this event's themes: rare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Vaneck Rare Earth And Strategic Metals Etf (REMX), and the dates in the story
REMX traded between 53.30 and 71.21 across 20 sessions. The latest close on file is 53.30.
How strong the case is around Vaneck Rare Earth And Strategic Metals Etf (REMX)
14 out of 100
“Shionogi pays $2B to acquire a rare disease startup” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.